Eli Lilly’s Omvoh® (mirikizumab-mkrz) has received FDA approval for treating moderately to severely active Crohn’s disease in adults, marking its…
Browsing: Clinical Updates
Fractyl Health announced promising early results from the REVEAL-1 cohort of the REMAIN-1 study, showing weight maintenance one month after…
A Polish observational study revealed that improved adenoma detection rates (ADR) among physicians with a baseline ADR below 26% significantly…
This comprehensive review by the AGA explores best practices in endoscopic enteral access, aiming to guide gastroenterologists in optimizing patient…
In 2024, pivotal advancements in gastrointestinal cancer research have emerged, spotlighting innovative treatments and potential new standards of care. Highlights…
The UK Biobank Pharma Proteomics Project, the largest study of circulating proteins, is set to revolutionize healthcare by enabling earlier…
A systematic review of 26 randomized controlled trials highlights that Eli Lilly’s experimental drug retatrutide achieves the greatest weight loss…
Endoscopic sleeve gastroplasty (ESG) has emerged as a promising non-surgical alternative for weight loss and liver health improvement, significantly outperforming…
Fecal microbiota transplantation (FMT) is a highly effective treatment for recurrent Clostridioides difficile infections, which affect 500,000 Americans annually and…
UC Riverside scientists have developed a groundbreaking nanopore-based diagnostic tool capable of detecting individual molecules with exceptional precision. This innovation…